The Challenge of Controlling Type 2 Diabetes
Each year in the US alone, over 1.5 million people are diagnosed with type 2 diabetes. Type 2 diabetes tends to get worse over time and can lead to serious health complications, such as cardiovascular disease and nerve damage. Combined with excess weight, the problem becomes a challenge many cannot overcome.
If you are trying to control your blood sugar levels, you know how difficult this can be. Daily diabetes medications can initially work well, but often become less effective over time and can lead to significant weight gain. As the disease progresses, many people need increasing amounts and combinations of medications that can have side effects. Ultimately, this can lead to daily insulin injections and concerns about hypoglycemia.
What is EndoBarrier®?
EndoBarrier is an investigational, non-surgical medical device designed to reduce blood sugar and help with weight loss. EndoBarrier is currently available at select centers in the United States through the STEP-1 Trial.
EndoBarrier is a thin, flexible sleeve that forms a physical barrier between the food you eat and the upper part of the small intestine. It is designed to change the way your body responds to food, which can help reduce blood sugar and help with weight loss. The mechanism is similar to Roux-en-Y gastric bypass, but through an outpatient non-surgical approach.
EndoBarrier is positioned at the upper part of the small intestine using an endoscope, that guides it through the mouth and into the stomach. Once EndoBarrier is in the proper position it is deployed, and the endoscope is removed.
EndoBarrier is not permanent. It is designed to stay in place for up to one year to help you manage you blood sugar and lose weight, and is then removed using an endoscope.
The EndoBarrier is currently only available in the US through the STEP-1 Trial. If you qualify and choose to join the trial, you will receive all study-related care and procedures at no cost.
See If You Qualify
To see if you might qualify for the STEP-1 Clinical Trial, and to get connected with your local study center to discuss the study further, please take the questionnaire below.